Drug Discovery 인포매틱스 시장 규모, 점유율, 성장 분석, 기능별, 용도별, 솔루션별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Drug Discovery Informatics Market Size, Share, and Growth Analysis, By Function (Sequencing and Target Data Analysis, Docking), By Application (Drug Discovery, Drug Development), By Solution, By End User, By Region - Industry Forecast 2025-2032
상품코드:1663026
리서치사:SkyQuest
발행일:2025년 02월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
Drug Discovery 인포매틱스 세계 시장 규모는 2023년 32억 9,000만 달러로 평가되었습니다. 2024년 36억 6,000만 달러에서 2032년에는 86억 2,000만 달러로 성장할 것으로 예상되며, 예측 기간(2025-2032년) 동안 11.3%의 연평균 복합 성장률(CAGR)을 보일 전망입니다.
세계 Drug Discovery 인포매틱스 시장은 생명공학 및 제약사들의 연구 투자 강화와 희귀질환 치료 및 희귀질환 치료제 개발에 대한 수요 증가로 인해 크게 성장하고 있습니다. 이러한 연구비 증가는 신약 개발에 있어 데이터 관리의 중요한 역할을 강조하고 있으며, 의약품 및 화합물에 대한 광범위한 데이터베이스는 의약품 연구에 필수적입니다. 현대의 인포매틱스는 고성능 컴퓨팅과 온라인 서비스 향상에 힘입어 효과적인 데이터 처리, 관리 및 분석을 위해 첨단 소프트웨어를 채택하고 있습니다. 또한, 의약품 개발에 대한 관심 증가, 새로운 치료제에 대한 수요 증가, 인실리코 분석의 보급이 시장 확대를 더욱 촉진하고 있습니다. 그러나 인포매틱스 도구와 관련된 높은 비용이 성장의 걸림돌이 될 수 있는 반면, 개발도상국의 신흥 바이오테크놀러지 분야에는 유리한 기회가 있습니다.
목차
서론
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porter의 Five Forces 분석
주요 시장 인사이트
중요 성공 요인
경쟁 정도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
규제 분석
기술 분석
특허 분석
Drug Discovery 인포매틱스 시장 규모 : 기능별
시장 개요
시퀀싱 및 타겟 데이터 분석
도킹
분자 모델링
라이브러리 및 데이터베이스 준비
기타 기능
Drug Discovery 인포매틱스 시장 규모 : 용도별
시장 개요
Drug Discovery
의약품 개발
임상전 시험
임상시험
Drug Discovery 인포매틱스 시장 규모 : 솔루션별
시장 개요
소프트웨어
서비스
Drug Discovery 인포매틱스 시장 규모 : 최종사용자별
시장 개요
제약회사
바이오테크놀러지 기업
조사 업무 수탁 기관(CRO)
기타 최종사용자
Drug Discovery 인포매틱스 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
주요 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업 개요
기업 상세
제품 포트폴리오 분석
기업 부문별 점유율 분석
전년대비 매출 비교(2022-2024년)
주요 기업 개요
IBM(United States)
Infosys Limited(India)
Thermo Fisher Scientific(United States)
PerkinElmer Inc.(United States)
Schrodinger, Inc.(United States)
Charles River Laboratories International, Inc.(United States)
Certara, Inc.(United States)
Accenture plc(Ireland)
Agilent Technologies, Inc.(United States)
Illumina, Inc.(United States)
Dassault Systemes SE(France)
Collaborative Drug Discovery, Inc.(United States)
Eurofins DiscoverX Products(United States)
Jubilant Biosys Limited(India)
Selvita S.A.(Poland)
Novo Informatics Pvt. Ltd.(India)
ChemAxon Ltd.(Hungary)
Albany Molecular Research Inc.(United States)
Boehringer Ingelheim GmbH(Germany)
Oracle Corporation(United States)
결론과 제안
LSH
영문 목차
영문목차
Global Drug Discovery Informatics Market size was valued at USD 3.29 billion in 2023 and is poised to grow from USD 3.66 billion in 2024 to USD 8.62 billion by 2032, growing at a CAGR of 11.3% during the forecast period (2025-2032).
The global drug discovery informatics market is witnessing significant growth driven by rising demand for rare illness treatments and orphan drug development, alongside enhanced research investment by biotechnology and pharmaceutical companies. This surge in research expenditure highlights the vital role of data management in drug discovery, where extensive databases of drugs and compounds are essential for pharmaceutical research. Modern informatics employs advanced software for effective data processing, management, and analysis, supported by improvements in high-performance computing and online services. Additionally, the growing focus on drug development, increasing need for new therapeutics, and widespread adoption of in silico modeling technology further propel market expansion. However, the high costs associated with informatics tools may hinder growth, while emerging biotech sectors in developing nations present lucrative opportunities.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery Informatics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Drug Discovery Informatics Market Segments Analysis
Global Drug Discovery Informatics Market is segmented by Function, Application, Solution, End User and region. Based on Function, the market is segmented into Sequencing and Target Data Analysis, Docking, Molecular Modelling, Library & Database Preparation and Other functions. Based on Application, the market is segmented into Drug Discovery and Drug Development. Based on Solution, the market is segmented into Software and Services. Based on End User, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs) and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Drug Discovery Informatics Market
The global drug discovery informatics market is significantly propelled by the swift developments in technology, especially in artificial intelligence (AI) and machine learning (ML). These innovations enhance data analysis capabilities, enabling researchers to process vast amounts of information swiftly and accurately. This increased efficiency not only streamlines the identification of molecular candidates for drug development but also expedites the overall drug discovery process. By harnessing powerful algorithms and predictive analytics, AI and ML are revolutionizing how pharmaceutical companies approach drug development, thereby driving the growth of the drug discovery informatics market on a global scale.
Restraints in the Global Drug Discovery Informatics Market
The Global Drug Discovery Informatics market faces significant obstacles due to concerns surrounding data protection and the necessity to adhere to legal regulations. Compliance with privacy laws, such as the General Data Protection Regulation (GDPR), complicates the management and sharing of critical information. As a result, these regulatory challenges hinder research efforts and create barriers that limit the adoption of advanced informatics technologies by companies. Consequently, this situation stifles innovation and growth within the market, making it increasingly difficult for organizations to leverage new insights and capabilities essential for advancing drug discovery processes on a global scale.
Market Trends of the Global Drug Discovery Informatics Market
The Global Drug Discovery Informatics market is witnessing a significant trend towards the increasing adoption of artificial intelligence (AI) and machine learning (ML) technologies. This shift is revolutionizing the industry by enhancing data analysis capabilities, expediting the identification of potential drug candidates, and leveraging predictive modeling to streamline the drug discovery process. As a result, pharmaceutical companies and research institutions are experiencing heightened creativity and operational efficiency, driving the demand for advanced informatics solutions. This trend indicates a transformative approach to drug discovery, promising more innovative therapies and faster time-to-market, thus positioning AI and ML as pivotal elements in the future of pharmacological research.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Technology Analysis
Patent Analysis
Global Drug Discovery Informatics Market Size by Function & CAGR (2025-2032)
Market Overview
Sequencing and Target Data Analysis
Docking
Molecular Modelling
Library & Database Preparation
Other functions
Global Drug Discovery Informatics Market Size by Application & CAGR (2025-2032)
Market Overview
Drug Discovery
Drug Development
Preclinical Testing
Clinical Trials
Global Drug Discovery Informatics Market Size by Solution & CAGR (2025-2032)
Market Overview
Software
Services
Global Drug Discovery Informatics Market Size by End User & CAGR (2025-2032)
Market Overview
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organization (CROs)
Other End Users
Global Drug Discovery Informatics Market Size & CAGR (2025-2032)
North America (Function, Application, Solution, End User)
US
Canada
Europe (Function, Application, Solution, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Function, Application, Solution, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Function, Application, Solution, End User)
Brazil
Rest of Latin America
Middle East & Africa (Function, Application, Solution, End User)
GCC Countries
South Africa
Rest of Middle East & Africa
Competitive Intelligence
Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
Company Details
Product Portfolio Analysis
Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
IBM (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Infosys Limited (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Thermo Fisher Scientific (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
PerkinElmer Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Schrodinger, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Charles River Laboratories International, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Certara, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Accenture plc (Ireland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Agilent Technologies, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Illumina, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Dassault Systemes SE (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Collaborative Drug Discovery, Inc. (United States)
